P38α subtype is a potential target to inhibit eNOS activity and NO production in human endothelial cells

Microvascular Research

Volumn 91, Issue , 2014, Pages 58-65

  Wang, Baoyu ^a   Xing, Feiyue ^a   Liu, Na ^a   Chen, Dingwu ^a   Li, Zhuo ^a   Liu, Jing ^b  

^a JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 14; NITRIC OXIDE;

ARTICLE; CELL INNER MEMBRANE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

BLOOD PRESSURE; CYTOPLASM; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMIDAZOLES; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASE 14; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PYRIDINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892373857     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.10.007     Document Type: Article

References (25)

1. Anter E., et al. p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. Circ. Res. 2005, 96:1072-1078.
2. Bivalacqua T.J., et al. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int. J. Impot. Res. 2000, 3:S8-S17.
3. Cieslik K., et al. Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma/Janus kinase 2/MEK-1-dependent pathway. J. Biol. Chem. 2001, 276:1211-1219.
4. Cuadrado A., et al. Mechanisms and functions of p38 MAPK signaling. Biochem. J. 2010, 429:403-417.
5. Davis M.E., Grumbach I.M., Fukai T., Cutchins A., Harrison D.G. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. J. Biol. Chem. 2004, 279:163-168.
6. Toit E.F., et al. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. Eur. J. Pharmacol. 2007, 556:115-120.
7. Gan L.M., et al. Temporal regulation of endothelial ET-1 and eNOS expression in intact human conduit vessels exposed to different intraluminal pressure levels at physiological shear stress. Cardiovasc. Res. 2000, 48:168-177.
8. Hoffmann A., et al. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J. Cell. Physiol. 2001, 188:33-44.
9. Kan W.H., H.J., Ba Z.F., Schwacha M.G., Chen J., Choudhry M.A., Bland K.I., Chaudry I.H. p38 MAPK-dependent eNOS upregulation is critical for 17beta-estradiol-mediated cardioprotection following trauma-hemorrhage. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2627-H2636.
10. Karantzoulis-Fegaras F., et al. Characterization of the human endothelial nitric-oxide synthase promoter. J. Biol. Chem. 1999, 274:3076-3093.
11. Leonard A.M., et al. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am. J. Hypertens. 2006, 19:1264-1269.
12. Li Y., et al. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell. Signal. 2000, 12:751-757.
13. Liou S.F., et al. San-Huang-Xie-Xin-Tang prevents rat hearts from ischemia/reperfusion-induced apoptosis through eNOS and MAPK pathways. Evid. Based Complement. Alternat. Med. 2011, 915051. (Epub 2011 Apr 14).
14. Liu L., et al. Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. FASEB J. 2006, 20:2594-2596.
15. Miller W.H., et al. Targeting endothelial cells with adenovirus expressing nitric oxide synthase prevents elevation of blood pressure in stroke-prone spontaneously hypertensive rats. Mol. Ther. 2005, 12:321-327.
16. Pollock J.S., et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10480-10484.
17. Tedesco L., et al. Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. Diabetes 2010, 59:2826-2836.
18. Tenhunen O., et al. Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart. Circ. Res. 2006, 99:485-493.
19. Thoms H.C., et al. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 2007, 67:1660-1669.
20. Toque H.A., et al. p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice. J. Sex. Med. 2010, 7:3857-3867.
21. Widmann C., et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 1999, 79:143-180.
22. Wu K.K. Regulation of endothelial nitric oxide synthase activity and gene expression. Nitric Oxide: Novel Actions, Deleterious Effects and Clinical Potential 2002, 962:122-130.
23. Wu Z., et al. p38 Mitogen-activated protein kinase is required for glucosamine-induced endothelial nitric oxide synthase uncoupling and plasminogen-activator inhibitor expression. Circ. J. 2012, 76:2015-2022.
24. Xing F., et al. Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation. Biochem. Cell Biol. 2006, 84:780-788.
25. Xing F., et al. Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway. J. Cell. Mol. Med. 2009, 13:1136-1148.